Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Goldman

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Molecular Diagnostics : JMD|August 10, 2012
Long-range PCR and next-generation sequencing of BRCA1 and BRCA2 in breast cancerHilmi Ozcelik, Xuejiang Shi, Martin C Chang, et al.
Proteomics|July 31, 2023
Multi-omics approach to socioeconomic disparity in metabolic syndrome reveals roles of diet and microbiomeFaraz Bishehsari, Michael Drees, Darbaz Adnan, et al.
Biological Psychiatry|August 19, 2008
Impact of the brain-derived neurotrophic factor Val66Met polymorphism on levels of hippocampal N-acetyl-aspartate assessed by magnetic resonance spectroscopic imaging at 3 TeslaAlexa J Stern, Antonina A Savostyanova, Aaron Goldman, et al.
Science Signaling|October 25, 2018
A call to arms: Unifying the fight against resistanceAlexis Kaushansky, Lizbeth Hedstrom, Aaron Goldman, et al.
Nanophotonics (Berlin, Germany)|September 30, 2021
Nanotherapeutic approaches to overcome distinct drug resistance barriers in models of breast cancerTanmoy Saha, Jayanta Mondal, Sachin Khiste, et al.
Plos Computational Biology|August 27, 2019
Cooperative adaptation to therapy (CAT) confers resistance in heterogeneous non-small cell lung cancerMorgan Craig, Kamran Kaveh, Alec Woosley, et al.
Cancer Research|October 15, 2013
Supramolecular nanoparticles that target phosphoinositide-3-kinase overcome insulin resistance and exert pronounced antitumor efficacyAshish A Kulkarni, Bhaskar Roy, Poornima S Rao, et al.
Science Signaling|August 22, 2019
Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug toleranceAaron Goldman, Sachin Khiste, Elizaveta Freinkman, et al.
Annals of the New York Academy of Sciences|September 29, 2011
Barrett's esophagus: prevalence and incidence of adenocarcinomasHelen M Shields, Gerardo Nardone, Jingjing Zhao, et al.
Frontiers in Immunology|July 9, 2024
Circulating immune and plasma biomarkers of time to HIV rebound in HIV controllers treated with vesatolimodMohamed Abdel-Mohsen, Steven Deeks, Leila Giron, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Molecular Diagnostics : JMD|August 10, 2012
Long-range PCR and next-generation sequencing of BRCA1 and BRCA2 in breast cancerHilmi Ozcelik, Xuejiang Shi, Martin C Chang, et al.
Proteomics|July 31, 2023
Multi-omics approach to socioeconomic disparity in metabolic syndrome reveals roles of diet and microbiomeFaraz Bishehsari, Michael Drees, Darbaz Adnan, et al.
Biological Psychiatry|August 19, 2008
Impact of the brain-derived neurotrophic factor Val66Met polymorphism on levels of hippocampal N-acetyl-aspartate assessed by magnetic resonance spectroscopic imaging at 3 TeslaAlexa J Stern, Antonina A Savostyanova, Aaron Goldman, et al.
Science Signaling|October 25, 2018
A call to arms: Unifying the fight against resistanceAlexis Kaushansky, Lizbeth Hedstrom, Aaron Goldman, et al.
Nanophotonics (Berlin, Germany)|September 30, 2021
Nanotherapeutic approaches to overcome distinct drug resistance barriers in models of breast cancerTanmoy Saha, Jayanta Mondal, Sachin Khiste, et al.
Plos Computational Biology|August 27, 2019
Cooperative adaptation to therapy (CAT) confers resistance in heterogeneous non-small cell lung cancerMorgan Craig, Kamran Kaveh, Alec Woosley, et al.
Cancer Research|October 15, 2013
Supramolecular nanoparticles that target phosphoinositide-3-kinase overcome insulin resistance and exert pronounced antitumor efficacyAshish A Kulkarni, Bhaskar Roy, Poornima S Rao, et al.
Science Signaling|August 22, 2019
Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug toleranceAaron Goldman, Sachin Khiste, Elizaveta Freinkman, et al.
Annals of the New York Academy of Sciences|September 29, 2011
Barrett's esophagus: prevalence and incidence of adenocarcinomasHelen M Shields, Gerardo Nardone, Jingjing Zhao, et al.
Frontiers in Immunology|July 9, 2024
Circulating immune and plasma biomarkers of time to HIV rebound in HIV controllers treated with vesatolimodMohamed Abdel-Mohsen, Steven Deeks, Leila Giron, et al.
Pageof 6